Elif Ates

Elif Ates

Auto-generated profile, based on publicly available information

Elif Ates


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 March 2025 in Klimik Dergisi/Klimik Journal
Verified
Journal Article
Open access
NSNuran Sarı
Nuran Sarı
EAElif Ates
Elif Ates
ÇEÇiğdem Erol
Çiğdem Erol
OAOzlem Kurt Azap
Ozlem Kurt Azap
ASAtilla Sezgin
Atilla Sezgin
Objective: This study aimed to investigate infections, microbiological agents, and factors affecting mortality in patients with end-stage heart failure who underwent left ventricular assist device (LVAD) surgery at our hospital since 2012, providing insights into patient follow-up and treatment strategies. Methods: This cross-sectional and retrospective study included 88 patients who underwent LVAD surgery at our hospital between 2012 and 2023 and subsequently developed infections. LVAD-specific and non-specific infections were classified according to the 2024 criteria of the International Society for Heart and Lung Transplantation (ISHLT). Results: A total of 88 patients who underwent LVAD implantation were included in the study. The mean age at implantation was 49.51±14.07 years, and the mean time to infection development was 17.90±13.55 months. Infections were observed in 94.3% of patients, while 45.4% developed sepsis and 53.4% had systemic inflammatory response syndrome (SIRS). The rate of intensive care unit admissions was 75.0%. Among the patients, 12.5% underwent debridement, 10.2% required complete device removal, and 6.8% underwent device exchange. The number of patients who underwent heart transplantation was 11, while 65 patients died. A total of 252 infection episodes were identified in 83 patients. The most common LVAD-specific infection was percutaneous driveline infection (40.8%). The most frequently observed clinical findings were discharge and fever, while Staphylococcus aureus and coagulase-negative staphylococci were the most commonly isolated pathogens. Nasal S. aureus carriage was detected in 27 (10.7%) patients, and among these, 16 ( 59.3%) patients developed S. aureus infections, which was statistically significant (p=0.001). Among Gram-negative bacteria, Pseudomonas aeruginosa and Escherichia coli were the most commonly isolated pathogens. Multidrug resistance (MDR) was observed in 35.4% of cases, while extended-spectrum beta-lactamase (ESBL) production was detected in 19.4%. Elevated creatinine levels, hypoalbuminemia, SIRS, and sepsis were found to be significantly associated with mortality (p<0.05). Additionally, age, Pitt bacteremia score, and Charlson comorbidity index were significantly higher in deceased patients, while INTERMACS scores were significantly lower (p<0.05). Conclusion: This study, conducted in patients with LVADs who have highly complex clinical conditions, provides significant insights into infection rates and factors influencing mortality. Our findings will contribute to future patient follow-up strategies and advanced-level research in this field.

30 September 2023 in Klimik Dergisi/Klimik Journal
Verified
Journal Article
Open access
NSNuran Sari
Nuran Sari
EKEmir Karacaglar
Emir Karacaglar
EAElif Ates
Elif Ates
BGBahadir Gultekin
Bahadir Gultekin
SKSeda Kabiroglu
Seda Kabiroglu
CICaner Incekas
Caner Incekas
Objective: Infective endocarditis is a serious disease with high morbidity and mortality due to serious embolic complications. The follow-up of the patients requires multidisciplinary evaluation. We aimed to share the experience of the infective endocarditis team in our hospital and to guide the work of the teams to be formed in the future. Methods: Our study was planned as descriptive, cross-sectional, and observational. The patients were diagnosed by the modified Duke criteria. The National Infective Endocarditis Consensus Report was considered during the diagnosis, follow-up, and treatment process. Results: Fifty (45.4%) of 110 patients followed by the team were diagnosed with endocarditis. Thirty of the patients (51.8%) were male, the median age was 63.5 (18-87) days, and the median duration of symptoms was 35.7 (1-180) days. 76% of the diagnoses were definite endocarditis, 46% of the cases had an acute course, aortic valve involvement was 38%, and native valve involvement was 60%; the most isolated agent was Stapyhylococcus aureus. Community-acquired infection was 46%. The most common predisposing factors were prosthetic heart valve (38%) and hemodialysis (46%). Fever was observed in 64% of the patients and dyspnea in 58%. The rate of detection of vegetation by transesophageal echocardiography was 68%. Brain, pulmonary embolisms, and spondylodiscitis were the most common complications. The median time for blood culture to become negative was 3 (3-15) days, the operation time for 15 patients was 8 (1-30) days, and the 30-day hospital mortality was 28%. A statistically significant correlation was found between mortality and the presence of previous endocarditis, ejection fraction below 50%, complication development, hospitalization in the intensive care unit, presence of thrombocytopenia, Charlson comorbidity index ≥5, and vegetation size ≥1 cm (p<0.05). We determined that the presence of previous endocarditis increased the risk of mortality 14 times (p=0.025). Conclusion: Mortality and morbidity rates can be reduced by detecting underlying diseases, controlling complications, applying early effective antibiotic and anticoagulant treatment, surgical interventions at the right time, and rapid supportive treatments for sepsis by teams formed with a multidisciplinary approach.